How to submit public comment or sign up to speak at the next Oregon Prescription Drug Affordability Board (PDAB) meeting!
Comment with this link: bit.ly/or-pdab-comment
#Oregon #PDAB #PrescriptionDrugCost #PublicComment #AffordabilityReviews
Key Meeting + Program Updates All PDAB meetings will now begin at 8:00 AM (starting Aug 20) One board member shared a conflict due to owning pharmacies Ralph Magrish left his role as Executive Director. The search is on for a new leader: deadline to apply is July 28 Applications for a new PDAB member have closed and are under review
Affordability Review Discussion Migraine meds: Ajovy, Emgality, Nurtec, Ubrelvy Differences in how they work and how they’re given Prior approvals are often required (which can delay treatment)
Affordability Review Discussion Continued Vraylar: Used a lot by Medicaid patients for schizophrenia Entresto: A heart failure drug with no alternative Worries about higher prices hurting people of color Some say it’s already affordable with help programs
Looking Ahead Next PDAB Meeting: August 20, 2025 @ 8 AM Focus on migraine drugs first Board packets will be clearer, with key info up front Board wants better ways to define “affordability”
In this week's meeting, the #Oregon Prescription Drug Affordability Board (#PDAB) focused on program changes their first drug #AffordabilityReviews. Learn more in the slides →
Next meeting: August 20, 2025 @ 8 AM.
#HealthPolicySky #Migraines #Ajovy #Emgality #Nurtec #Ubrelvy #Vraylar #Entresto #OCAP
